AQR Capital Management
BIVV

AQR Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

AQR Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,760,862
Closed -$94.9M – 2330
2017
Q4 		$94.9M Buy
1,760,862
+227,874
+15% +$12.5M 0.1% 253
2017
Q3 		$87.5M Buy
1,532,988
+594,098
+63% +$34.8M 0.1% 248
2017
Q2 		$56.5M Buy
938,890
+799,551
+574% +$45.5M 0.07% 339
2017
Q1 		$7.59M Buy
+139,339
New +$6.86M 0.01% 853

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

AQR Capital Management's BIVV Position: Q1 2018 in Review

AQR Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,760,862 shares — an estimated $94.9M sold.

AQR Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $94.9M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • AQR Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • AQR Capital Management sold 1,760,862 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $94.9M.
  • AQR Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • AQR Capital Management's Bioverativ Inc. Common Stock position peaked at $94.9M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on AQR Capital Management's 13F filing for Q1 2018, filed 15 May 2018.